Translating GPCR Signal Biology into Therapy: Emerging Trends and Future Direction

Abstract

G protein-coupled receptors (GPCRs) constitute one of the largest and most diverse families of cell surface receptors and play a central role in mediating a wide range of physiological processes. They transduce extracellular stimuli—such as hormones, neurotransmitters, and environmental signals—into intracellular responses via G protein activation. Because of their pivotal role in signal transduction, GPCRs are major therapeutic targets for cancer, cardiovascular disease, metabolic disorders, and neurological conditions. Recent advances in structural biology, particularly X-ray crystallography and cryo-electron microscopy, have significantly deepened our molecular understanding of GPCR architecture, ligand binding, and activation mechanisms. These insights have enabled structure-based drug design and the development of more selective, effective therapeutics. Moreover, the complexity of GPCR signaling characterized by biased agonism, allosteric modulation, and receptor dimerization—creates opportunities to design drugs with improved specificity and fewer side effects. As precision medicine advances, research is increasingly focused on personalized strategies that account for individual genetic and proteomic profiles to target specific GPCR subtypes or signaling pathways. Overall, the unique and versatile signaling capabilities of GPCRs keep them at the forefront of pharmaceutical innovation, offering substantial potential for next-generation therapeutics that are safer, more effective, and tailored to individual patient needs.